Viewing nowCombinationSimroks A Tablet
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
HanKook Pavis Pharmaceutical Co., Ltd.

MFDS item code 201601727 · Approved 2016.03.31
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication helps lower elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides in patients with primary hypercholesterolemia, while increasing good cholesterol, HDL cholesterol. It is particularly used as an adjunct to existing lipid-lowering treatments in patients with homozygous familial hypercholesterolemia or when other treatments are ineffective. This medication is effective when used with dietary modification and non-drug treatments that include restriction of saturated fats and cholesterol, aiming to reduce the risk of atherosclerotic vascular diseases caused by hypercholesterolemia. Additionally, before administration, it is important to check for other conditions that could cause dyslipidemia, such as diabetes or hypothyroidism, and treat them if necessary. If a patient experiences an acute cardiovascular event while hospitalized, it is important to quickly assess lipid levels to inform the treatment plan. This medication is used to improve lipid levels related to hypercholesterolemia to reduce the risk of cardiovascular disease.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.
This medication may cause serious muscle-related side effects, such as myopathy and rhabdomyolysis. These side effects can manifest as muscle pain, muscle tenderness, and muscle weakness, accompanied by significantly elevated creatine kinase levels in the blood. The risk is particularly heightened with high doses, so patients taking 80mg should exercise extra caution. If any unusual muscle symptoms occur, the patient must inform their physician immediately and discontinue the medication if necessary. This medication should not be used by patients with allergies to its ingredients, those with active liver disease or persistent liver function abnormalities, or women who are pregnant or breastfeeding. Additionally, the risk of myopathy increases when taken with certain powerful medications, so they should not be taken together. This medication may affect liver function; therefore, patients with abnormal liver function test results should use it with caution, and regular liver function tests are necessary during therapy. Elderly patients or those with impaired kidney function may also have an increased risk of muscle-related side effects while taking this medication and should be monitored closely. During the use of this medication, if unexplained muscle pain, weakness, or tenderness occurs, the patient must inform healthcare personnel immediately and should also notify if they are prescribed any new medications. Women of childbearing potential should avoid pregnancy while taking this medication, and should discontinue it immediately if pregnancy is confirmed. Moreover, this medication can increase blood concentration when taken with certain enzyme-inhibiting drugs, raising the risk of side effects, so patients must consult with their physician about any concomitant medications. Data regarding the safety of this medication in children and adolescents is limited, therefore it is not recommended for children under 10 years of age. There is no specific antidote for overdose; therefore, if overdose is suspected, the patient should seek appropriate treatment at a medical facility immediately.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Temperature should be maintained at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness and safety over time.
White to light yellow, double convex, rectangular tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
HanKook Pavis Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.